Healthcare >> Analyst Interviews >> July 28, 2003

Investing In Biotechnology: Rahul Jasuja – Techvest Llc

RAHUL JASUJA is a Research Analyst at Techvest, LLC. Prior to joining Techvest, he served as biotechnology Research Analyst for the New York investment banking firm of Rodman & Renshaw. He conducted equity research in various areas of molecular medicine, including immunotherapy, oncology, cardiology and tissue engineering. Previously, he served as a biopharmaceutical industry analyst at Business Communications Company Inc., a technology analysis and market research firm, where he authored reports on numerous biotechnology topics. Dr. Jasuja received his scientific training in immunology at Tufts Medical School and Harvard Medical School. He has conducted research in the areas of cell signaling, cancer biology, T-lymphocyte adhesion and activation, and macrophage arachidonic acid metabolism. At Tufts Medical School he taught and supervised medical and dental students in the field of immunology. Dr. Jasuja received his BSc from St. Xavier's College, Bombay (India), his MS in Microbiology and Molecular Biology from the University of Montana and his PhD in Immunology from Tufts Medical School in Boston. Profile
TWST: Would you begin with a quick overview of Techvest?

Dr. Jasuja: Techvest is a boutique biotechnology/medical device

investment banking and equity research firm that has its